HOXA10 and ovarian carcinoma: Moreover, upregulated expression of HOXA10 was shown to promote epithelial mesenchymal transition as well as proliferation, migration and invasion of ovarian cancer cells and decrease patient survival (Jiang et al., 2014; Liu et al., 2018; Nie et al., 2021).